The study, coordinated by Vall d’Hebron, aims to facilitate access for all children and adolescents with cancer to personalized medicine regardless of their place of residence
SEHOP-PENCIL will establish a state coordination strategy with 10 hubs or genomic centers that will have the capacity to sequence blood samples and tumors that arrive from other hospitals
Knowing the biology of the tumor is important to identify specific alterations that allow improving diagnosis, offering targeted therapies, stratifying patients according to their risk and detecting syndromes predisposing to the development of tumors, all to improve survival and reduce sequelae.
| Adjunct | Size |
|---|---|
| Press release | 201.04 KB |
